Project Grant R34DA063431
Award Date 8/15/25
Completion Date 7/31/28
Dollars Obligated $753K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,442,434 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant aims to advance evidence regarding place-based naloxone implementation and overdose reversal readiness in high-risk settings, using public libraries as a test case. The...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
- This Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the effects of opioids on HIV transcription and latency. The $234,000 award to Georgetown University will support research using a novel dual fluorescent and bioluminescent virus called EcoHIV NL4-3 Dual Red to visualize active HIV proviral transcription in microglia and astrocytes. The study will examine the mechanisms by which...
- This federal Project Grant award of $193,644 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports a multi-level epidemiological study conducted by The Trustees of Columbia University in the City of New York. The study aims to examine how individuals transition through different substance use profiles, the determinants of these transitions, and polysubstance use profiles at increased risk of overdose. The research plan leverages the...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $4,725,000 to the University of California, Los Angeles (UCLA) to develop new dissemination strategies that improve the availability and user-friendliness of research on preventing HIV transmission and effectively treating substance use disorders (SUDs). The project aims to mitigate policy-level barriers and upstream barriers that hinder access...
- This $189,500.00 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to determine the extent to which cardiovascular disease (CVD) affects people with opioid use disorder (OUD) and identify ways to prevent CVD in this population. To achieve this, the project will: 1) Examine the relationship between CVD and OUD using Transformed...
- This federal Project Grant award, titled "Integrated Services for PWID Using Person-Centered Interactions, Reach, and Engagement (INSPIRE)", is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The University of Maryland, Baltimore was awarded $219,291 on September 30, 2025 to co-adapt and evaluate an HIV status-neutral collaborative care management model for HIV prevention, HIV care, mental health, and medication...
- This federal Project Grant award of $4,665,000 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund the development and testing of a novel, nurse-led "Community-Based Opioid Treatment (CBOT)" model to deliver opioid use disorder treatment and HIV prevention and care services directly in the community setting. The goal is to improve long-term...
- This federal Project Grant award of $240,108 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to elucidate the corticostriatal and neuroimmune mechanisms underlying HIV-induced dysregulation of reward seeking. The award to Drexel University will support research to identify novel treatment targets for individuals with co-occurring cocaine use disorders and HIV. The project will leverage animal models to investigate how HIV...